Projecting the Potential Cost Effectiveness of Ocrelizumab...

Projecting the Potential Cost Effectiveness of Ocrelizumab Versus Standard Care in Primary Progressive Multiple Sclerosis Patients Under Alternative Pricing Scenarios

Suh, K, Carlson, JJ, Garrison, LP
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
19
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2016.03.200
Date:
May, 2016
File:
PDF, 80 KB
english, 2016
Conversion to is in progress
Conversion to is failed